Alveus Therapeutics has filed a notice of an exempt offering of securities to raise $110,724,980.00 in New Funding.
According to filings with the U.S. Securities and Exchange Commission, Alveus Therapeutics is raising up to $110,724,980.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold…